Haleon, Pfizer and Sensodyne
Pfizer to sell about $3.25 bln stake in Sensodyne-maker Haleon, bookrunner says
Sept 30 (Reuters) - Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million shares worth about $3.25 billion with strong demand from investors, a bookrunner familiar with the offering said on Monday.
Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...
(Reuters) - Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon, a ...
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health ...
Sensitive care toothpaste brand Sensodyne has launched an all-in-one care toothpaste 'Sensodyne Complete Protection Plus'.It ...
According to the woman, her teeth were prone to damage and breaking, making it nearly impossible for her to brush her teeth.
DoctorsOfJoy aims to highlight how dentists empower individuals to fully enjoy life's moments by addressing oral health ...
Goldman Sachs, JP Morgan, Morgan Stanley and UBS are global coordinators on the trade, with Barclays, Bank of America, BNP ...
California Governor Gavin Newsom has signed a bill that requires automakers selling internet-connected cars to do more to ...
Pfizer Inc. announced a further reduction of its stake in Haleon Plc, offering to sell about a 5.9% stake in the UK consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback